360 related articles for article (PubMed ID: 15570635)
1. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
[TBL] [Abstract][Full Text] [Related]
2. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature.
Ostensen M; Hartmann H; Salvesen K
J Rheumatol; 2000 Aug; 27(8):1872-5. PubMed ID: 10955326
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
6. First-trimester exposure to alprazolam.
St Clair SM; Schirmer RG
Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome following fetal exposure to tiaprofenic acid in the first trimester.
Pastuszak A; Pinelli M; Koren G
Am J Perinatol; 1993 Sep; 10(5):354-7. PubMed ID: 8240592
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
[TBL] [Abstract][Full Text] [Related]
9. Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic.
Nurmohamed L; Moretti ME; Schechter T; Einarson A; Johnson D; Lavigne SV; Erebara A; Koren G; Finkelstein Y
Am J Obstet Gynecol; 2011 Dec; 205(6):533.e1-3. PubMed ID: 21907957
[TBL] [Abstract][Full Text] [Related]
10. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
12. Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study.
Bernard N; Elefant E; Carlier P; Tebacher M; Barjhoux CE; Bos-Thompson MA; Amar E; Descotes J; Vial T
BJOG; 2013 Apr; 120(5):568-74. PubMed ID: 23346916
[TBL] [Abstract][Full Text] [Related]
13. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.
Weber-Schoendorfer C; Hoeltzenbein M; Wacker E; Meister R; Schaefer C
Rheumatology (Oxford); 2014 Apr; 53(4):757-63. PubMed ID: 24369411
[TBL] [Abstract][Full Text] [Related]
14. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome.
Idris I; Srinivasan R; Simm A; Page RC
Clin Endocrinol (Oxf); 2005 Nov; 63(5):560-5. PubMed ID: 16268809
[TBL] [Abstract][Full Text] [Related]
15. Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study.
Bar-Oz B; Clementi M; Di Giantonio E; Greenberg R; Beer M; Merlob P; Arnon J; Ornoy A; Zimmerman DM; Berkovitch M
Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):176-9. PubMed ID: 15808375
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: management issues during pregnancy.
Ferrero S; Pretta S; Ragni N
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):3-9. PubMed ID: 15223156
[TBL] [Abstract][Full Text] [Related]
17. Fetal outcome following roxithromycin exposure in early pregnancy.
Chun JY; Han JY; Ahn HK; Choi JS; Koong MK; Nava-Ocampo AA; Koren G
J Matern Fetal Neonatal Med; 2006 Mar; 19(3):189-92. PubMed ID: 16690513
[TBL] [Abstract][Full Text] [Related]
18. [Follow-up of 151 pregnant women exposed to antidepressant treatment (MAOI excluded) during organogenesis].
Brunel P; Vial T; Roche I; Bertolotti E; Evreux JC
Therapie; 1994; 49(2):117-22. PubMed ID: 7817334
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
Chun-Fai-Chan B; Koren G; Fayez I; Kalra S; Voyer-Lavigne S; Boshier A; Shakir S; Einarson A
Am J Obstet Gynecol; 2005 Mar; 192(3):932-6. PubMed ID: 15746694
[TBL] [Abstract][Full Text] [Related]
20. Threatened miscarriage as a predictor of obstetric outcome.
Johns J; Jauniaux E
Obstet Gynecol; 2006 Apr; 107(4):845-50. PubMed ID: 16582121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
